Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues	$ 6,382	$ 4,957
Costs and expenses:
Cost of sales	3,423	2,928
Selling, general and administrative	3,341	3,345
Research and development	570	376
Costs and Expenses	7,334	6,649
Operating loss	(952)	(1,692)
Interest income	279	311
Other (expense) income, net	(66)	1,673
(Loss) income before income taxes	(739)	292
Income tax expense	0	(11)
Net (loss) income	$ (739)	$ 281
Net (loss) income per common share:
Basic net (loss) income per common share (in dollars per share)	$ (0.02)	$ 0.01
Diluted net (loss) income per common share (in dollars per share)	$ (0.02)	$ 0.01
Weighted-average number of common shares outstanding:
Basic (in shares)	30,718,000	30,385,000
Diluted (in shares)	30,718,000	30,756,000